Published in World J Gastroenterol on April 28, 2006
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg (2010) 1.76
Laparoscopy-assisted combined resection for synchronous gastric and colorectal cancer: report of three cases. Surg Today (2009) 1.05
Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med J (2007) 0.95
Laparoscopic surgery for synchronous gastric and colorectal cancer: a preliminary experience. Langenbecks Arch Surg (2009) 0.92
Second primary cancers in patients with gastric cancer. Radiol Oncol (2010) 0.91
Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer. Surg Today (2007) 0.90
Metachronous double primary cancer after diagnosis of gastric cancer. Cancer Res Treat (2012) 0.88
Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid. Ann Surg Treat Res (2015) 0.86
Clinical significance of colonoscopy in patients with upper gastrointestinal polyps and neoplasms: a meta-analysis. PLoS One (2014) 0.85
Is colonoscopic screening necessary for patients with gastric adenoma or cancer? Dig Dis Sci (2013) 0.82
Multiple primary cancers in extracolonic sites with colorectal cancer. Int J Colorectal Dis (2008) 0.82
Clinical features of second primary cancers arising in early gastric cancer patients after endoscopic resection. World J Gastroenterol (2015) 0.80
The value of preoperative screening colonoscopies in patients with biliary tract cancer. J Gastroenterol (2015) 0.77
Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia. Mol Clin Oncol (2012) 0.76
Simultaneous laparoscopy-assisted resection for rectal and gastric cancer. JSLS (2014) 0.75
Concurrent robot-assisted distal gastrectomy and partial nephrectomy for synchronous early gastric cancer and renal cell carcinoma: an initial experience. J Gastric Cancer (2014) 0.75
Role of computed tomographic colonoscopy of postoperative surveillance in patient with gastric cancer. World J Gastroenterol (2007) 0.75
Synchronous double primary gastric and endometrial cancer: a case report and literature review. Int J Clin Exp Pathol (2015) 0.75
Management of synchronous adenocarcinoma of the esophago-gastric junction and ampulla of Vater: case report of a surgically challenging condition. Patient Saf Surg (2009) 0.75
Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases. Case Rep Oncol (2016) 0.75
Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study. World J Gastroenterol (2014) 0.75
Laparoscopic resection of synchronous gastric cancer and primary small intestinal lymphoma: a case report. World J Gastroenterol (2014) 0.75
Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer? J Korean Med Sci (2017) 0.75
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med (2005) 5.88
Gastric carcinoma. N Engl J Med (1995) 5.77
Recurrence following curative resection for gastric carcinoma. Br J Surg (2000) 4.67
Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol (2005) 3.63
Multiple primary malignant neoplasms: historical perspectives. Cancer (1977) 2.11
Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology (2004) 1.81
Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer (2000) 1.71
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer (2005) 1.70
Features of second primary cancer in patients with gastric cancer. Oncology (2003) 1.46
The risk of gastrointestinal and other primary malignant diseases following gastric cancer. Acta Oncol (1991) 1.26
Multiple primary malignancies of the upper aerodigestive system. Ann Otol Rhinol Laryngol (1980) 1.20
Multiple primary cancers in the stomach and another organ: frequency and the effects on prognosis. Jpn J Clin Oncol (1985) 1.16
Microsatellite instability is a genetic marker for the development of multiple gastric cancers. Int J Cancer (2001) 1.15
Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol (2005) 1.09
Preoperative evaluation of gastric cancer: value of spiral CT during gastric arteriography (CTGA). Abdom Imaging (2001) 1.04
Multiple primary cancers of breast and cervix uteri: an epidemiological approach to analysis. Br J Cancer (1981) 1.02
Second malignancy in stomach cancer patients and its possible risk factors. Jpn J Clin Oncol (1986) 0.91
Multiple synchronous primaries of the gastrointestinal tract: a molecular case report. Cancer Lett (1996) 0.85
Multiple primary cancers in autopsy cases of Tokyo University Hospital (1883-1982) and in Japan Autopsy Annuals (1974-1982). Jpn J Clin Oncol (1985) 0.84
Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat (2005) 11.27
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol (2011) 6.18
Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg (2008) 4.95
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science (2011) 4.13
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol (2005) 4.03
Prolongation of the period between biopsy and EMR can influence the nonlifting sign in endoscopically resectable colorectal cancers. Gastrointest Endosc (2008) 3.05
Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol (2012) 2.97
2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat (2004) 2.90
Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. J Thorac Oncol (2011) 2.89
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet (2008) 2.89
The learning curve for EMR with circumferential mucosal incision in treating intramucosal gastric neoplasm. Gastrointest Endosc (2005) 2.76
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. J Clin Oncol (2007) 2.62
Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol (2013) 2.16
Surgical complications and the risk factors of laparoscopy-assisted distal gastrectomy in early gastric cancer. Ann Surg Oncol (2008) 2.10
Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology (2010) 2.00
Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy. Gastric Cancer (2011) 1.98
Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg (2010) 1.84
Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc (2009) 1.63
Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Ann Surg Oncol (2010) 1.54
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.53
Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K/Akt and MAPK signaling pathways. Int J Mol Sci (2010) 1.53
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs. Lung Cancer (2010) 1.52
Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol (2009) 1.51
Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc (2010) 1.51
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol (2009) 1.51
Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg (2008) 1.51
Neutralized rocuronium (pH 7.4) before administration prevents injection pain in awake patients: a randomized prospective trial. J Clin Anesth (2007) 1.50
Neonatal hair nicotine levels and fetal exposure to paternal smoking at home. Am J Epidemiol (2008) 1.48
Feasibility of laparoscopic techniques as the surgical approach of choice for primary colorectal cancer: an analysis of 570 consecutive cases. Surg Endosc (2008) 1.48
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging (2005) 1.42
Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev (2005) 1.41
Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: a comparative study with laparoscopy-assisted distal gastrectomy. J Surg Oncol (2009) 1.41
Optimal submucosal invasion of early gastric cancer for endoscopic resection. Ann Surg Oncol (2015) 1.39
Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res (2004) 1.37
Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J Gastroenterol (1999) 1.34
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol (2003) 1.33
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2006) 1.33
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer (2012) 1.31
Site-specific incorporation of methyl- and acetyl-lysine analogues into recombinant proteins. Angew Chem Int Ed Engl (2008) 1.30
Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay. J Clin Microbiol (2010) 1.30
Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2011) 1.29
Surgical indication for non-curative endoscopic resection in early gastric cancer. Ann Surg Oncol (2007) 1.26
Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One (2012) 1.26
Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. J Palliat Med (2007) 1.25
Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene (2004) 1.24
Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol (2007) 1.23
Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. Int J Colorectal Dis (2007) 1.23
Characteristics of synchronous cancers in gastric cancer patients. Cancer Res Treat (2006) 1.22
Hepatic splenosis diagnosed as hepatocellular carcinoma: report of a case. Surg Today (2002) 1.22
Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc (2013) 1.22
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer (2011) 1.22
Weekly irinotecan in patients with metastatic gastric cancer failing cisplatin-based chemotherapy. Jpn J Clin Oncol (2004) 1.22
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Breast (2011) 1.21
Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet (2003) 1.21
Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res (2005) 1.20
Is the sentinel node biopsy clinically applicable for limited lymphadenectomy and modified gastric resection in gastric cancer? A meta-analysis of feasibility studies. J Surg Oncol (2011) 1.18
A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology (2010) 1.17